Development of technology for the chicken gut microbiome, colibacillosis and disease prevention
First written in FY2017. 2 of 3 entries say "Restated". Latest entry: FY2021.
2 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「For broilers, one of its core products, the company is conducting research into technologies to improve the chicken gut microbiome, identifying the types and transmission routes of colibacillosis, and developing more effective disease-prevention measures.」
The company continues research into the broiler gut microbiome, colibacillosis and disease-prevention measures. - FY2019RestatedAnnual report
「The company is conducting research into technologies to improve the chicken gut microbiome, identifying the types and transmission routes of colibacillosis, and developing more effective disease-prevention measures.」
The company continues to pursue the gut microbiome, colibacillosis and disease-prevention measures as themes in the development of rearing technologies for broilers and other livestock. - FY2017First statedAnnual report
「For broilers, one of its core products, the company is conducting research into technologies to improve the chicken gut microbiome, identifying the types and transmission routes of colibacillosis, and developing more effective disease-prevention measures.」
The company’s research themes for improving broiler productivity and quality include the gut microbiome, transmission routes of colibacillosis and disease-prevention measures.